Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Marking Minute: How Presco Utilized PVC as PPE when the Coronavirus Pandemic Hit

You may know Presco for its barricade tape or marking flags, but a number of new customers got to know the company this year during the coronavirus pandemic. Presco quickly got up and running, creating personal protective equipment (PPE) solutions using PVC. John Yianitsas, Vice President of New Business Development at Presco, said PVC…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Marking Minute: How Presco Utilized PVC as PPE when the Coronavirus Pandemic Hit

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

You may know Presco for its barricade tape or marking flags, but a number of new customers got to know the company this year during the coronavirus pandemic.

Presco quickly got up and running, creating personal protective equipment (PPE) solutions using PVC.

John Yianitsas, Vice President of New Business Development at Presco, said PVC is a great fit when making PPE because it creates a tough-to-penetrate barrier, is easily cleanable, and can be either heat sealed or sewed. That gives users not only the opportunity to use PVC items more than once but also to utilize the material in a number of different ways.

“PVC can be used not only just for gowns, but drapes, barriers, and things like that, which is why I think it’s such a great product that can be used over and over again. It’s not a one-and-done,” Yianitsas said.

Few could say they saw a pandemic coming, so there was a rush to get PPE to those who needed it at the beginning of the pandemic. Luckily for those relying on Presco, the Texas-based company was able to turn around its products quickly since it was relying only on domestic materials and not waiting for supplies to arrive from abroad.

“I think the key factor in all this is the fact that we’re a domestic supplier. We source all our raw materials domestically, so we didn’t have to wait for anything to come in,” Yianitsas said. “Our ability to take an order and turn it around and fulfill it very, very quickly, the fact that we’re here in Sherman, Texas, gave us that opportunity to be able to respond very, very, quickly. Had we not had that capability, we would’ve been in the same boat as other people.”

Instead, Presco was able to help frontline workers in the United States do their job in a safe way, aiding the response when the country needed it most.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512